Top compounds associated with response to FXYD6-FXYD2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.055 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.053 0.2
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tandutinib CTRPv2 pan-cancer AAC 0.051 0.2
mRNA CIL70 CTRPv2 pan-cancer AAC 0.067 0.2
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.11 0.2
mRNA importazole CTRPv2 pan-cancer AAC 0.054 0.2
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.046 0.2
Download CSV